Clorox is trading 4.3% higher at $93.79 on November 3 after reporting fiscal first-quarter sales and adjusted earnings above analyst estimates. - Sales were $1.91 billion, and adjusted earnings were $1.55 per share; both exceeded analyst estimates. - Management expects full-year adjusted EPS near the low end of its $5.70–$6.00 range and lowered its gross-margin outlook to about 41.5% amid higher costs.